iBio Ownership | Who Owns iBio?
iBio Ownership Summary
iBio is owned by 34.00% institutional investors, 3.95% insiders, and 62.04% retail investors. Lynx1 capital management lp is the largest institutional shareholder, holding 10.06% of IBIO shares.
IBIO Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | iBio | 34.00% | 3.95% | 62.04% |
| Sector | Healthcare Stocks | 42.54% | 10.82% | 46.64% |
| Industry | Biotech Stocks | 45.21% | 10.75% | 44.04% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Lynx1 capital management lp | 1.06M | 10.06% | $874.07K |
| Ikarian capital | 617.33K | 5.88% | $511.02K |
| Ameriprise financial | 482.30K | 4.59% | $399.25M |
| Opaleye management | 375.00K | 3.57% | $310.43K |
| Vanguard group | 274.07K | 2.61% | $226.93K |
| Boothbay fund management | 176.86K | 1.68% | $146.41K |
| Geode capital management | 151.31K | 1.44% | $125.25K |
| Two sigma securities | 45.08K | 0.43% | $37.32K |
| Blackrock funding, inc. /de | 42.73K | 0.41% | $35.37K |
| Virtu financial | 41.90K | 0.40% | $35.00K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Lynx1 capital management lp | 1.06M | 0.18% | $874.07K |
| Ikarian capital | 617.33K | 0.05% | $511.02K |
| Opaleye management | 375.00K | 0.04% | $310.43K |
| Two sigma securities | 45.08K | 0.01% | $37.32K |
| Adar1 capital management | 27.00K | 0.00% | $22.35K |
| Boothbay fund management | 176.86K | 0.00% | $146.41K |
| Virtu financial | 41.90K | 0.00% | $35.00K |
| Hrt financial lp | 34.16K | 0.00% | $28.00K |
| Ameriprise financial | 482.30K | 0.00% | $399.25M |
| Tower research capital llc (trc) | 1.73K | - | $1.44K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ameriprise financial | 482.30K | 0.00% | 482.30K |
| Vanguard group | 274.07K | - | 130.21K |
| Geode capital management | 151.31K | - | 39.01K |
| Hrt financial lp | 34.16K | 0.00% | 34.16K |
| Boothbay fund management | 176.86K | 0.00% | 17.41K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Lynx1 capital management lp | 1.06M | 0.18% | -482.68K |
| Iridian asset management llc/ct | - | - | -58.20K |
| Cubist systematic strategies | - | - | -55.60K |
| Quadrature capital | - | - | -28.85K |
| Ubs group | 1.00 | - | -28.60K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Ameriprise financial | 482.30K | 0.00% | 482.30K | $399.25M |
| Hrt financial lp | 34.16K | 0.00% | 34.16K | $28.00K |
| Financial gravity companies | 2.00 | - | 2.00 | $2.00 |
| Financial gravity asset management | 2.00 | - | 2.00 | $2.00 |
Sold Out
| Holder | Change |
|---|---|
| Fmr | -1.00 |
| Atlantic union bankshares | -14.00 |
| Harbour investments | -40.00 |
| Group one trading | -156.00 |
| Two sigma investments, lp | -13.48K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2025 | 32 | 6.67% | 3,569,988 | 11.42% | 34 | 3.22% | 14 | - | 6 | 200.00% |
| Jun 30, 2025 | 30 | -9.09% | 3,203,758 | 23.84% | 32 | 4.72% | 13 | -23.53% | 2 | - |
| Mar 31, 2025 | 33 | 13.79% | 2,587,118 | -0.97% | 26 | 3.21% | 17 | 142.86% | 2 | -66.67% |
| Dec 31, 2024 | 29 | -6.45% | 2,612,402 | 0.19% | 28 | 3.14% | 7 | -12.50% | 6 | 20.00% |
| Sep 30, 2024 | 31 | 14.81% | 2,607,512 | 6.38% | 30 | 3.74% | 8 | - | 5 | -44.44% |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jan 10, 2025 | Duran Felipe | Chief Financial Officer | Buy | $25.00K |
| Jan 10, 2025 | Brenner Martin | See Remarks | Buy | $25.00K |
| Jan 10, 2025 | Banjak Marc | Chief Legal Officer | Buy | $25.00K |
| Jan 10, 2025 | Arkowitz David | - | Buy | $50.00K |
| Jan 10, 2025 | Clark William D | - | Buy | $5.00K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q4 | - | - |
| 2025 Q1 | 7 | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
| 2024 Q2 | - | - |
IBIO Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools